1. CDC. Common eye disorders and diseases; 2020. Available from: https://www.cdc.gov/visionhealth/basics/ced/index.html. Accessed October 14, 2020.
2. Age-Related Macular Degeneration Preferred Practice Pattern®
3. HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
4. Novartis Pharmaceuticals Corporation. BEOVU- Brolucizumab Injection, Solution, [package insert]; 2022. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d. Accessed February 13, 2023.
5. Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab